Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Medical Device Representatives topic
No spam. Unsubscribe anytime.
Bill to certify medical‑device representatives draws sharp division between hospitals and industry/sterile‑processing advocates
Summary
A bill to require certification and expanded credentialing for medical‑device representatives drew sharply divided testimony at the Public Health Committee: sterile‑processing and vendor‑safety witnesses urged device‑specific training to prevent contamination of loaner surgical trays, while hospitals and surgeons warned mandatory state certification would add cost and delay patient care.
Lawmakers heard sharply contrasting testimony on Senate Bill 1372, which would require education, certification and tighter credentialing for medical‑device representatives who enter operating rooms and handle instruments and loaner trays.
Industry and pro‑bill testimony: Several current and former device representatives said current vendor‑credentialing standards (ANSI/NEMA vendor access tiers) treat medical‑device reps the same as construction workers or pharmaceutical sales staff and do not reflect the device‑specific infection control and loaner‑tray management responsibilities representatives perform. "Loaner trays often arrive the day before surgery; they need device‑specific instructions for use (IFUs) and tray‑management knowledge," said Carter Lonsberry, a long‑time industry veteran and founder of a hospital vendor safety organization. Sterile‑processing specialists said inconsistent documentation and last‑minute deliveries can increase bioburden risk and delay cases. Peter Daigle and David Jagrass, sterile processing experts, testified that a national certification for device reps and a common reporting mechanism would improve patient safety and standardize training across hospitals.
Hospital and trade‑group opposition: Hospitals and several surgeons opposed a statutory certification requirement. The Connecticut Hospital Association argued the bill would create unnecessary cost and inefficiency and risk delaying access to device support in time‑sensitive cases; CHA and clinicians said vendors are subject to hospital credentialing, Joint Commission standards and FDA device regulation already. "Medical device representatives do not provide care or treatment to patients; they serve as technical support," said Karen Buckley of CHA. Surgeon Kathleen LaVorgna told the committee that hospitals already vet vendors and that most devices arrive pre‑sterilized; she opposed new statutory mandates.
Points of dispute: Witnesses disagreed about how frequently loaner trays lack IFUs, whether representatives ever participate hands‑on in the sterile field, and whether hospitals’ current credentialing and value‑analysis processes are adequate and consistently enforced. Some nurses and device reps described instances where trays arrived incomplete or late and where device-specific cleaning instructions were missing; some surgeons said those events are rare and that hospital policies already address the risk.
Next steps: The committee asked for more evidence and specifics about infection‑control incidents tied to device rep practices, how certification would be implemented nationally, and whether a voluntary standard or improved hospital credentialing processes could close observed gaps without a new state license.
Ending: The hearing exposed a practical gap: device reps perform technical work that interfaces with sterile processing and the OR, but industry, clinical and hospital stakeholders diverge on whether statutory certification or improved hospital practices and vendor oversight are the right remedy.
